Serum Tumor Marker Dynamics as Predictive Biomarkers in NSCLC Chemo-Immunotherapy and Mono-Immunotherapy Maintenance: A Registry-Based Descriptive Study

Serum Tumor Marker Dynamics as Predictive Biomarkers in NSCLC Chemo-Immunotherapy and Mono-Immunotherapy Maintenance: A Registry-Based Descriptive Study

David Lang,1,2 Wolfgang Haslinger,2 Kaveh Akbari,2,3 Mario Scala,2,3 Benedikt Hergan,2,3 Christian Asel,2,3 Andreas Horner,1,2 Romana Wass,1,2 Elmar Brehm,1,2 Bernhard Kaiser,1 Bernd Lamprecht1,2 1Johannes Kepler University Hospital, Department of Pulmonology, Linz, Austria; 2Johannes Kepler Univers...

Full description

Bibliographic Details
Main Authors: Lang D, Haslinger W, Akbari K, Scala M, Hergan B, Asel C, Horner A, Wass R, Brehm E, Kaiser B, Lamprecht B
Format: Article
Language:English
Published: Dove Medical Press 2020-12-01
Series:Lung Cancer : Targets and Therapy
Subjects:
carcinoembryonic antigen
platinum doublet chemotherapy
pembrolizumab
cyfra 21-1
recist
nivolumab
Online Access:https://www.dovepress.com/serum-tumor-marker-dynamics-as-predictive-biomarkers-in-nsclc-chemo-im-peer-reviewed-article-LCTT

Internet

https://www.dovepress.com/serum-tumor-marker-dynamics-as-predictive-biomarkers-in-nsclc-chemo-im-peer-reviewed-article-LCTT

Similar Items